Vaccines to Prevent Coccidioidomycosis: A Gene-Deletion Mutant of Coccidioides Posadasii as a Viable Candidate for Human Trials

Coccidioidomycosis is an endemic fungal infection that is reported in up to 20,000 persons per year and has an economic impact close to $1.5 billion. Natural infection virtually always confers protection from future exposure, and this suggests that a preventative vaccine strategy is likely to succee...

Descripción completa

Detalles Bibliográficos
Autores principales: Galgiani, John N., Shubitz, Lisa F., Orbach, Marc J., Mandel, M. Alejandra, Powell, Daniel A., Klein, Bruce S., Robb, Edward J., Ohkura, Mana, Seka, Devin J., Tomasiak, Thomas M., Monath, Thomas P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410110/
https://www.ncbi.nlm.nih.gov/pubmed/36012826
http://dx.doi.org/10.3390/jof8080838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410110/
https://www.ncbi.nlm.nih.gov/pubmed/36012826
http://dx.doi.org/10.3390/jof8080838

Ejemplares similares